The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Th17 and natural Treg cell population dynamics in systemic lupus erythematosus
Abstract
Objective: To investigate the relative abundance and activities of Th17 cells and natural Treg cells in systemic lupus erythematosus (SLE). Methods: Blood samples were collected from 50 adult patients with SLE. Samples were processed to detect Th17 cells and natural Treg cells by flow cytometry, and related gene expression was assessed by real‐time reverse transcription–polymerase chain reaction. Skin biopsy specimens were collected for histologic assessment. The function of Th17 cells in relation to human umbilical vein endothelial cells (HUVECs) was studied in vitro. Th17 cells were also examined in lupus‐prone MRL/Mp‐lpr/lpr (MRL/lpr) mice. Results: We demonstrated the presence of Th17 cells among the peripheral blood mononuclear cells (PBMCs) and in the involved organs of patients with active SLE. Both the percentage of circulating Th17 cells and the ability to produce interleukin‐17A (IL‐17A) were increased in samples derived from patients with active SLE. The number of Th17 cells increased during SLE flare, especially in patients with vasculitis, and decreased following certain treatments. We observed that IL‐17A from patients with SLE could induce adhesion molecule messenger RNA expression in HUVECs and adhesion of T cells to HUVECs. An increase in the percentage of Th17 cells was correlated with natural Treg cell depletion during disease flare. Finally, expansion of the Th17 cell population was detected in MRL/lpr mice. Conclusion: SLE flare might be linked to the expansion of the Th17 cell population and the depletion of natural Treg cell subpopulations. Expansion of the Th17 cell population might be related to a distinct cytokine environment in active SLE. Th17 cells and microenvironmental IL‐17A are involved in vascular inflammation in SLE. Antagonism of Th17 cells by IL‐17A–blocking antibodies should be explored as a treatment of SLE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Mosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
Derivation of the sledai. A disease activity index for lupus patients
Bombardier, C., Gladman, D. D., Urowitz, M. B., Caron, D., Chang, C. H., Austin, A., Bell, A., Bloch, D. A., Corey, P. N., Decker, J. L., et al. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350606 · Cited by 4,570
Functional diversity of helper T lymphocytes
Abbas, A. K., Murphy, K. M., & Sher, A. (1996) · Nature · doi:10.1038/383787a0 · Cited by 4,450
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
Self-citation
Cited by
Maddur, M. S., Miossec, P., Kaveri, S. V., & Bayry, J. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.03.044 · Cited by 619
Immunopathogenic mechanisms of systemic autoimmune disease
Wahren-Herlenius, M., & Dörner, T. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60954-x · Cited by 593
He, J., Zhang, X., Wei, Y., Sun, X., Chen, Y., Deng, J., Jin, Y., Gan, Y., Hu, X., Jia, R., et al. (2016) · Nature Medicine · doi:10.1038/nm.4148 · Cited by 572
Self-citationSex-specific differences in hypertension and associated cardiovascular disease
Colafella, K. M. M., & Denton, K. M. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.189 · Cited by 490
Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential
Dankers, W., Colin, E. M., van Hamburg, J. P., & Lubberts, E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00697 · Cited by 442
Immunological pathogenesis and treatment of systemic lupus erythematosus
Pan, L., Lu, M.-P., Wang, J.-H., Xu, M., & Yang, S.-R. (2020) · World Journal of Pediatrics · doi:10.1007/s12519-019-00229-3 · Cited by 411
Yang, W., Shen, N., Ye, D.-Q., Liu, Q., Zhang, Y., Qian, X.-X., Hirankarn, N., Ying, D., Pan, H.-F., Mok, C. C., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000841 · Cited by 404
Modulation of inflammatory and immune responses by vitamin D
Colotta, F., Jansson, B., & Bonelli, F. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.07.007 · Cited by 399
Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview
Schinocca, C., Rizzo, C., Fasano, S., Grasso, G., La Barbera, L., Ciccia, F., & Guggino, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.637829 · Cited by 360
Pathogenesis of human systemic lupus erythematosus: recent advances
Crispín, J. C., Liossis, S.-N. C., Kis-Toth, K., Lieberman, L. A., Kyttaris, V. C., Juang, Y.-T., & Tsokos, G. C. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.12.005 · Cited by 359
Neutrophils in the pathogenesis and manifestations of SLE
Kaplan, M. J. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.132 · Cited by 343
Human FoxP3+ regulatory T cells in systemic autoimmune diseases
Miyara, M., Gorochov, G., Ehrenstein, M., Musset, L., Sakaguchi, S., & Amoura, Z. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.05.004 · Cited by 342
Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with Systemic Lupus Erythematosus
Cunninghame Graham, D. S., Morris, D. L., Bhangale, T. R., Criswell, L. A., Syvänen, A.-C., Rönnblom, L., Behrens, T. W., Graham, R. R., & Vyse, T. J. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002341 · Cited by 334
Regmi, S., Pathak, S., Kim, J. O., Yong, C. S., & Jeong, J.-H. (2019) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2019.04.002 · Cited by 314
Emerging cell and cytokine targets in rheumatoid arthritis
Burmester, G. R., Feist, E., & Dörner, T. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.168 · Cited by 307
Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus
Shah, K., Lee, W.-W., Lee, S.-H., Kim, S. H., Kang, S. W., Craft, J., & Kang, I. (2010) · Arthritis Research & Therapy · doi:10.1186/ar2964 · Cited by 301
Sarcoidosis is a Th1/Th17 multisystem disorder
Facco, M., Cabrelle, A., Teramo, A., Olivieri, V., Gnoato, M., Teolato, S., Ave, E., Gattazzo, C., Fadini, G. P., Calabrese, F., et al. (2011) · Thorax · doi:10.1136/thx.2010.140319 · Cited by 295
IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential
Zhu, S., & Qian, Y. (2012) · Clinical Science · doi:10.1042/cs20110496 · Cited by 282
T cells as therapeutic targets in SLE
Crispín, J. C., Kyttaris, V. C., Terhorst, C., & Tsokos, G. C. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.60 · Cited by 271
Th17 cells in inflammation and autoimmunity
Singh, R. P., Hasan, S., Sharma, S., Nagra, S., Yamaguchi, D. T., Wong, D. T. W., Hahn, B. H., & Hossain, A. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.08.019 · Cited by 266
Cytokines in Autoimmunity: Role in Induction, Regulation, and Treatment
Moudgil, K. D., & Choubey, D. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0065 · Cited by 265
Wang, D., Huang, S., Yuan, X., Liang, J., Xu, R., Yao, G., Feng, X., & Sun, L. (2017) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.89 · Cited by 259
Cardiac myosin-Th17 responses promote heart failure in human myocarditis
Myers, J. M., Cooper, L. T., Kem, D. C., Stavrakis, S., Kosanke, S. D., Shevach, E. M., Fairweather, D., Stoner, J. A., Cox, C. J., & Cunningham, M. W. (2016) · JCI Insight · doi:10.1172/jci.insight.85851 · Cited by 230
Zhao, M., Tan, Y., Peng, Q., Huang, C., Guo, Y., Liang, G., Zhu, B., Huang, Y., Liu, A., Wang, Z., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-02890-0 · Cited by 122
Self-citationProtein phosphatase 2A enables expression of interleukin 17 (IL-17) through chromatin remodeling
Apostolidis, S. A., Rauen, T., Hedrich, C. M., Tsokos, G. C., & Crispín, J. C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.483743 · Cited by 91
Prado, C., de Paz, B., Gómez, J., López, P., Rodríguez-Carrio, J., & Suárez, A. (2011) · Rheumatology · doi:10.1093/rheumatology/ker227 · Cited by 33
Potential role of regulatory B cells in immunological diseases
Valizadeh, A., Sanaei, R., Rezaei, N., Azizi, G., Fekrvand, S., Aghamohammadi, A., & Yazdani, R. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.08.004 · Cited by 16
Identification of Acvr2a as a Th17 Cell-Specific Gene Induced during Th17 Differentiation
IHN, H.-J., KIM, D. H., OH, S.-S., MOON, C., CHUNG, J. W., SONG, H., & KIM, K. D. (2011) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.110436 · Cited by 9
Metadata
- Authors
- Yang, J., Chu, Y., Yang, X., Gao, D., Zhu, L., Yang, X., Wan, L., & Li, M.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2009-04-29
- Volume
- 60
- Issue
- 5
- Pages
- 1472-1483
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2055712900
- Cited by
- 444
- References
- 51
- FWCI
- 21.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.